Mucinex maker Reckitt Beckiser’s new “simpler and more effective organization” won’t include 190 New Jersey workers. | ...

When Reckitt Benckiser Group Plc set out last year to sell a portfolio of homecare brands, including household names such as ...

Reckitt Benckiser Group PLC (RBGLY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in ...

As part of a sweeping reorganization effort, Reckitt Benckiser Group plans to eliminate 190 jobs in New Jersey this year.

Reckitt Benckiser Group PLC closed 8.64% short of its 52-week high of £54.18, which the company reached on March 7th.

Reckitt Benckiser’s Mead Johnson unit and Abbott Laboratories have been ordered to face a new trial in the US over allegations their premature infant formula can cause a serious gut condition.

Abbott Laboratories (ABT) shares declined and Reckitt Benckiser shares ended the day lower in London after Reckitt said a state judge ruled plaintiffs could seek a retrial against the infant formula ...

Barclays analyst Iain Simpson lowered the firm’s price target on Reckitt Benckiser (RBGLY) to 5,550 GBp from 5,600 GBp and keeps an Equal ...

Reckitt Benckiser Group PLC closed 12.40% short of its 52-week high of £54.18, which the company reached on March 7th.

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in ...

UBS analyst Guillaume Delmas maintained a Buy rating on Reckitt (RKT – Research Report) today and set a price target of £77.00. The company’s ...

Abbott Laboratories (ABT) shares declined and Reckitt Benckiser shares ended the day lower in London after Reckitt said a state judge ruled plaintiffs could seek a retrial against the infant ...